Executive Summary
TechPrecision Corporation delivered QQ4 2024 revenue of approximately $8.60 million, up 14.6% year-over-year and 12.4% quarter-over-quarter, driven by stronger demand and product mix in select end markets within its Ranor and Stadco segments. Despite top-line growth, the quarter remained unprofitable, with net income of about -$5.12 million and an EPS of -$0.58. Gross profit rose to roughly $1.23 million, producing a gross margin of 14.28%, a material improvement year-over-year but insufficient to offset operating and non-operating costs. EBITDA ran negative at about -$1.79 million, and operating income was -$2.46 million, contributing to a net margin of -59.55%. These results reflect continued structural cost challenges and a heavy fixed-cost base within the current volume framework. Cash flow was weak despite modest operating cash generation: net cash from operating activities was $0.13 million, free cash flow was -$0.32 million, and the company ended the period with cash and equivalents of about $138k. The reported liquidity metrics show a tenuous short-term balance, with a current ratio of 0.84 and a quick ratio of 0.65, highlighting balance sheet fragility as the company works through its cost structure and working capital requirements. The FX translation effect reported in the cash flow line appears anomalous in the dataset and warrants careful verification in the companyβs filings. Looking ahead, absent a material improvement in gross margin and a sustained reduction in operating expenses, TechPrecision faces a protracted path to sustained profitability. Management commentary is not available in the provided transcript, limiting insight into near-term guidance or strategic pivots. This analysis provides a disciplined view of the quarterβs fundamentals, liquidity posture, and strategic implications for investors.
Key Performance Indicators
QoQ: -146.87% | YoY:-234.96%
QoQ: -491.80% | YoY:-410.70%
Key Insights
Revenue: $8.60 million; YoY +14.59%, QoQ +12.42%
Gross Profit: $1.228 million; YoY +44.88%, QoQ +5.82%; Gross Margin: 14.28%
Operating Income: -$2.459 million; Margin: -28.59%
EBITDA: -$1.786 million; EBITDA Margin: -20.77%
Net Income: -$5.121 million; Net Margin: -59.55%; EPS: -$0.58
Liquidity and leverage: Cash $0.138 million; Total debt $12.703 million; Net debt $12.565 million; Current ratio 0.84; Quick ratio 0.65; Cash ratio 0.0078; Debt to equity 1.63; Interest coverage negative (~-14.55x)...
Financial Highlights
Revenue: $8.60 million; YoY +14.59%, QoQ +12.42%
Gross Profit: $1.228 million; YoY +44.88%, QoQ +5.82%; Gross Margin: 14.28%
Operating Income: -$2.459 million; Margin: -28.59%
EBITDA: -$1.786 million; EBITDA Margin: -20.77%
Net Income: -$5.121 million; Net Margin: -59.55%; EPS: -$0.58
Liquidity and leverage: Cash $0.138 million; Total debt $12.703 million; Net debt $12.565 million; Current ratio 0.84; Quick ratio 0.65; Cash ratio 0.0078; Debt to equity 1.63; Interest coverage negative (~-14.55x)
Cash flow: Operating cash flow $0.125 million; Free cash flow -$0.323 million; Net change in cash -$0.253 million; FX impact shown as $263.024 million in the dataset (appears anomalous); Cash balance end of period $0.138 million; Shares outstanding 8.777 million; Basic and diluted EPS -$0.58
Income Statement
Metric |
Value |
YoY Change |
QoQ Change |
Revenue |
8.60M |
14.59% |
12.42% |
Gross Profit |
1.23M |
44.88% |
5.82% |
Operating Income |
-2.46M |
-234.96% |
-146.87% |
Net Income |
-5.12M |
-410.70% |
-491.80% |
EPS |
-0.58 |
N/A |
-487.04% |
Key Financial Ratios
operatingProfitMargin
-28.6%
operatingCashFlowPerShare
$0.01
freeCashFlowPerShare
$-0.04
Management Commentary
Transcript not provided in the data set. As a result, there are no management quotes or themes to extract for this quarter. Highlights section is thus populated with quantitative outcomes and inferred implications from the reported results rather than qualitative commentary.
Forward Guidance
No explicit management guidance or commentary from an earnings call is available in the provided data. Given the continued losses and weak liquidity, investors should monitor (i) efforts to reduce fixed SG&A and operating costs, (ii) margin expansion initiatives in high-margin end markets (defense, aerospace, nuclear), (iii) liquidity improvements including working capital optimization and potential balance sheet restructuring, and (iv) any disclosed capital allocation plans (capital expenditures vs. debt reduction vs. potential strategic initiatives). In the absence of stated targets, the plausibility and achievability of a near-term path to breakeven will hinge on sustained revenue growth in higher-margin segments and a material reduction in operating expenses. Key factors to watch: quarterly gross margin progression, SG&A run-rate, working capital dynamics, debt maturities, and any progress on product mix optimization that leverages the companyβs two segments Ranor and Stadco.